针对TGF-β受体I的小分子抑制剂的结构见解和临床进展
Carlota Leonardo-Sousa1, Rodrigo Barriga1, Helena F Florindo1
1Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.
Molecular therapy. Oncology
|March 21, 2025
概括
针对转化生长因子β受体I (TGF-βRI) 的小分子抑制剂在治疗癌症和纤维化方面表现有前途. 这些TGF-βRI抑制剂可以通过克服治疗耐药性来增强癌症免疫疗法.
科学领域:
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 失调的转化生长因子β (TGF-β) 信号驱动诸如癌症之类的疾病.
- TGF-β 阻碍了癌症免疫疗法的有效性,特别是免疫检查点抑制剂.
- 用小分子准TGF-β受体I (TGF-βRI) 提供了一个治疗策略.
研究的目的:
- 审查小分子TGF-βRI抑制剂的发展.
- 分析TGF-βRI结构生物学和结合相互作用.
- 探索TGF-βRI抑制剂的临床试验数据和专利文献.
主要方法:
- 对TGF-βRI的高分辨率X射线晶体结构的分析.
- 对八种TGF-βRI抑制剂的临床试验数据的审查.
- 2000年1月至2024年5月的专利文献调查.
主要成果:
- 详细介绍了TGF-βRI结合相互作用的结构洞察力.
- 临床试验中的八种TGF-βRI抑制剂在机制,选择性和潜力方面进行了讨论.
- 总结了20多年来TGF-βRI抑制剂开发中的制药创新.
结论:
- 巩固的知识有助于设计下一代TGF-βRI抑制剂.
- TGF-βRI 抑制剂解决了瘤学和纤维化的未满足需求.
- 将TGF-βRI抑制剂与免疫检查点抑制剂相结合可能会增强癌症免疫疗法.
相关概念视频
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Activation of Integrins
3.2K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.2K
GTPases and their Regulation
8.2K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
8.2K
G Protein-coupled Receptors
11.0K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.0K


